800-551-0488

Lab results are too important to go anywhere else

Beaumont Laboratory

Vitamin B12 Binding Capacity

ARUP #70260, EPIC: LAB6349, SOFT: XVB12

Instructions

  • The patient should fast for 12-15 hours prior to specimen collection.
  • The patient should refrain from taking Vitamin B12 supplements for 72 hours prior to specimen collection.

Specimen Collection Criteria

Collect (preferred specimen): One Gold-top SST tube.
Also acceptable: One plain Red-top tube.

Physician Office/Drawsite Specimen Preparation

Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Transfer serum to a plastic transport tube and refrigerate (2-8°C or 36-46°F).

Preparation for Courier Transport

Transport: 1.0 mL serum, refrigerated (2-8°C or 36-46°F). (Min: 0.1 mL)

Rejection Criteria

  • Specimens not collected and processed as indicated.

Storage

Specimen Stability for Testing:

Room Temperature (20-26°C or 68-78.8°F): 6 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): 1 month

Specimen Storage in Department Prior to Disposal:

Specimen retention time is determined by the policy of the reference laboratory. Contact the Sendout Laboratory with any questions.

Laboratory

Sent to ARUP Laboratories, Salt Lake City, UT.

Performed

Monday, Thursday.
Results available within 2-6 days.

Reference Range

800-2600 pg/mL.

Test Methodology

Quantitative Radioimmunoassay (RIA).

Interpretation

  • This assay measures the unsaturated binding capacity of serum for Vitamin B12.
  • Elevated B12B occurs in various myeloproliferative disorders, especially chronic myelocytic leukemia and polycythemia vera, or any condition where the peripheral granulocyte pool is increased.
  • Elevated B12B levels have also been reported in some hepatomas, where an unusual tumor-related R binder may occur.
  • Altered levels of B12B have been reported in liver disease and increased B12B has been associated with Gaucher's disease.
  • A rare congenital lack of transcobalamin II, which results in a severe megaloblastic anemia, results in low B12B levels.
  • The performance characteristics of this test were validated by ARUP Laboratories, Inc. The U.S. Food and Drug Administration (FDA) has not approved this test. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. ARUP is authorized under Clinical Laboratory Improvement Amendments (CLIA) and by all states to perform high-complexity testing.

Clinical Utility

The determination of serum unsaturated B12 binding capacity (B12B) may be of use in the investigation of various myeloproliferative disorders, especially chronic myelocytic leukemia and polycythemia vera, or any condition where the peripheral granulocyte pool is increased, some hepatomas, Gaucher's disease and in cases of severe megaloblastic anemia resulting from a congenital lack of transcobalamin II.

CPT Code

82608.

Test Codes

ARUP #70260, EPIC: LAB6349, SOFT: XVB12

Last Updated

12/19/2016

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.

This directory currently reflects information only for specimens collected and/or processed at the Farmington Hills, Grosse Pointe, Royal Oak, and Troy campuses.